PRESIDIO PHARMACEUTICALS
Updated 15 days ago
1700 Owens Street, Suite 184 San Francisco, CA 94158 USA
Presidio Pharmaceuticals, Inc. is a San Francisco-based clinical-stage pharmaceutical company dedicated to the development and licensing of its small-molecule antiviral therapeutic, ravidasvir (PPI-668) in the treatment of hepatitis C virus (HCV) infection.
Also known as: Presidio, Presidio Pharmaceuticals, Inc
Associated domains: presidiopharma.wordpress.com, ravidasvir.com, ravidasvirhydrochloride.com